Skip to main navigation Skip to search Skip to main content

Application of fullerenes in nanomedicine: An update

  • Anthony Dellinger
  • , Zhiguo Zhou
  • , James Connor
  • , Ab Madhankumar
  • , Sarala Pamujula
  • , Christie M. Sayes
  • , Christopher L. Kepley

Research output: Contribution to journalReview articlepeer-review

Abstract

Fullerenes are carbon spheres presently being pursued globally for a wide range of applications in nanomedicine. These molecules have unique electronic properties that make them attractive candidates for diagnostic, therapeutic and theranostic applications. Herein, the latest research is discussed on developing fullerene-based therapeutics as antioxidants for inflammatory diseases, their potential as antiviral/bacterial agents, utility as a drug delivery device and the promise of endohedral fullerenes as new MRI contrast agents. The recent discovery that certain fullerene derivatives can stabilize immune effector cells to prevent or inhibit the release of proinflammatory mediators makes them potential candidates for several diseases such as asthma, arthritis and multiple sclerosis. Gadolinium-containing endohedral fullerenes are being pursued as diagnostic MRI contrast agents for several diseases. Finally, a new class of fullerene-based theranostics has been developed, which combine therapeutic and diagnostic capabilities to specifically detect and kill cancer cells.

Original languageEnglish (US)
Pages (from-to)1191-1208
Number of pages18
JournalNanomedicine
Volume8
Issue number7
DOIs
StatePublished - Jul 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • General Materials Science

Fingerprint

Dive into the research topics of 'Application of fullerenes in nanomedicine: An update'. Together they form a unique fingerprint.

Cite this